Marc Rodger

Dr. Marc Rodger was appointed the Chair of the McGill University Department of Medicine, Physician-in-Chief, McGill University Health Center, and the Harry Webster Thorp Professor of Medicine in January 2020 and has been reappointed for a second term in January 2025. He obtained his MD (Magna Cum Laude) from the University of Ottawa after completing his BSc in Physiology at McGill. He completed his post-graduate medical training at UBC and the University of Ottawa and completed an MSc in Epidemiology.

Dr. Rodger’s teaching, clinical care, and research focus on venous thromboembolism (VTE). He has an active research program exploring novel therapeutic strategies for VTE and VTE diagnosis and prevention in pregnancy. Dr Rodger has over 290 publications, including first/senior author papers in the Lancet and New England Journal of Medicine. Dr. Rodger co-founded the CIHR-funded CanVECTOR (Canadian Venous Thrombosis Clinical Trials and Outcomes Research) Network (www.CanVECTOR.ca). He founded INVENT (International Network of Venous Thrombosis Clinical Research Networks) (www.INVENT-VTE.com), where he is former Chair and current volunteer Executive Director. INVENT includes 10 national research networks with over 450 investigators in over 150 research sites throughout the world.

Tel.: 514-843-1578
Fax: 514-843-8182